ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)

Technical Analysis Report for USA stock CRSP Crispr Therapeutics. Dated: 28 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics

Crispr Therapeutics Opened at 58.22 and Closed at: 57.72, which is -2.86% of previous session's close. It moved within a range of 57.10 and 59.37
The session was a Bearish session with an average volume of 1388700, which is 14.42% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Golden cross was found 5 days back on long term averages

Support for tomorrow is 56.28 and resistance for tomorrow is 58.55
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 56.76, 55.79 resistance for tomorrow's hourly charts is 59.03, 60.33

10 Day SMA for Crispr Therapeutics (CRSP) is 57.91 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Crispr Therapeutics (CRSP) is 55.42 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Crispr Therapeutics (CRSP) is 53.35 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 53.08 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Crispr Therapeutics is 53.15 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Crispr Therapeutics is at 55.42 and 200 DMA is at 53.15, while 50 DMA and 100 DMA are at 53.35 and 53.08 respectively

Crispr Therapeutics (CRSP) moving average of 20 SMA is at 55.42 and 20 EMA is at 55.88

Crispr Therapeutics (CRSP) moving average of 50 SMA is at 53.35 and 50 EMA is at 53.86

Crispr Therapeutics (CRSP) moving average of 100 SMA is at 53.08 and 100 EMA is at 53.32

Crispr Therapeutics (CRSP) moving average of 200 SMA is at 53.15 and 200 EMA is at 52.64

Crispr Therapeutics has performed better than Pfizer Inc in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Novo Nordisk in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Glaukos Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Davita Inc in short term. Holding Crispr Therapeutics could be a better choice for now!

China Sxt has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in China Sxt, about 3633.56% more returns!

Scholar Rock has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Scholar Rock, about 9.62% more returns!

Crispr Therapeutics has performed better than Ultragenyx Pharmaceutical in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Neurocrine Biosciences in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Ironwood Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Fulgent Genetics in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Eloxx Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics has performed better than Axogen Inc in short term. Holding Crispr Therapeutics could be a better choice for now!

Atossa Genetics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Atossa Genetics, about 2.45% more returns!

Crispr Therapeutics has performed better than Angiodynamics Inc in short term. Holding Crispr Therapeutics could be a better choice for now!

Crispr Therapeutics Technical analysis of indicators

Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.

MACD generated a BUY signal for Crispr Therapeutics in short term and the buy signal is strong.

Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Crispr Therapeutics in short term but SELL signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Crispr Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 58.32 and Crispr Therapeutics CRSP stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.

Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CRSP Experts View which covers a lot of information including buying and selling signals

CRSP future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here

Chart Crispr Therapeutics (CRSP)  Technical (Analysis) Reports Crispr Therapeutics [

Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Crispr Therapeutics (CRSP)  Technical (Analysis) Reports Crispr Therapeutics [

 

Back to top